Talk:Irinotecan

Pharmacology Mid‑importance

	This article is within the scope of WikiProject Pharmacology, a collaborative effort to improve the coverage of Pharmacology on Wikipedia. If you would like to participate, please visit the project page, where you can join the discussion and see a list of open tasks.PharmacologyWikipedia:WikiProject PharmacologyTemplate:WikiProject Pharmacologypharmacology articles
Mid	This article has been rated as Mid-importance on the project's importance scale.

Medicine Mid‑importance

	Medicine portal This article is within the scope of WikiProject Medicine, which recommends that medicine-related articles follow the Manual of Style for medicine-related articles and that biomedical information in any article use high-quality medical sources. Please visit the project page for details or ask questions at Wikipedia talk:WikiProject Medicine.MedicineWikipedia:WikiProject MedicineTemplate:WikiProject Medicinemedicine articles
Mid	This article has been rated as Mid-importance on the project's importance scale.

Ideal sources for Wikipedia's health content are defined in the guideline Wikipedia:Identifying reliable sources (medicine) and are typically review articles. Here are links to possibly useful sources of information about Irinotecan.

PubMed provides review articles from the past five years (limit to free review articles)
The TRIP database provides clinical publications about evidence-based medicine.
Other potential sources include: Centre for Reviews and Dissemination and CDC

Chemotherapy

Latest comment: 14 years ago1 comment1 person in discussion

can't this article at least use the word "chemotherapy" to describe this drug also used in combo with cetuximab successfully —Preceding unsigned comment added by 70.129.7.137 (talk) 07:47, 13 December 2009 (UTC)Reply

A new FDA approved formulation

Latest comment: 6 years ago1 comment1 person in discussion

"On October 22, 2015, the FDA approved irinotecan liposome injection (Onivyde)" [1] - Should it be added to this article ? -

Sure. As a second line agent I have moved it to the body of the article and formatted the ref. Doc James (talk · contribs · email) 06:31, 13 February 2018 (UTC)Reply

This article needs adjusting

Latest comment: 2 years ago1 comment1 person in discussion

I'll edit if I get time but I'm not every efficient at this unfortunately. Irinotecan has more uses and combinations than stated in this article - part of Folfirinox which is considered 1st line for pancreatic cancer in the much of the UK ( https://www.pancreaticcancer.org.uk/information/treatments-for-pancreatic-cancer/chemotherapy/folfirinox/ ), it can be used alongside cetuximab ( https://www.cancer.gov/about-cancer/treatment/drugs/folfiri-cetuximab ) and separately panitumumab ( https://www.cancerresearchuk.org/about-cancer/cancer-in-general/treatment/cancer-drugs/drugs/panitumumab ). — Preceding unsigned comment added by Nexttime4 (talk • contribs) 23:23, 20 January 2022 (UTC)Reply

Add topic